These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 33441977

  • 1. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.
    Fukushima K, Kitada S, Komukai S, Kuge T, Matsuki T, Kagawa H, Tsujino K, Miki M, Miki K, Kida H.
    Sci Rep; 2021 Jan 13; 11(1):1178. PubMed ID: 33441977
    [Abstract] [Full Text] [Related]

  • 2. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M.
    J Infect Chemother; 2006 Aug 13; 12(4):195-202. PubMed ID: 16944258
    [Abstract] [Full Text] [Related]

  • 3. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul 13; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 4. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T, Matsui H, Hirose T, Suzuki J, Saito M, Akaba T, Kobayashi K, Akashi S, Kawashima M, Tamura A, Nagai H, Akagawa S, Kobayashi N, Ohta K.
    BMC Infect Dis; 2016 Jan 27; 16():31. PubMed ID: 26818764
    [Abstract] [Full Text] [Related]

  • 5. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
    Fujita M, Kajiki A, Tao Y, Miyazaki M, Ouchi H, Harada E, Ikegame S, Matsumoto T, Uchino J, Watanabe K, Nakanishi Y.
    J Infect Chemother; 2012 Apr 27; 18(2):146-51. PubMed ID: 21927844
    [Abstract] [Full Text] [Related]

  • 6. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ, Wu TS, Chiang PC, Lee MH.
    J Microbiol Immunol Infect; 2007 Aug 27; 40(4):342-8. PubMed ID: 17712469
    [Abstract] [Full Text] [Related]

  • 7. The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
    Kadota JI, Kurashima A, Suzuki K.
    J Infect Chemother; 2017 May 27; 23(5):293-300. PubMed ID: 28254517
    [Abstract] [Full Text] [Related]

  • 8. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
    Kobashi Y, Okimoto N, Matsushima T, Shigetou E, Kuraoka T, Takeyama H, Eda R, Yano S, Kobayashi K, Ohnishi T, Mori K, Ueda Y, Moritaka T, Nishimura K, Abe T.
    Kekkaku; 2002 Jun 27; 77(6):435-41. PubMed ID: 12136597
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N, Nishimura T, Ohtani S, Takeshita K, Fukunaga K, Tasaka S, Urano T, Ishii K, Miyairi M, Ishizaka A.
    Chest; 2009 Dec 27; 136(6):1569-1575. PubMed ID: 19542259
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H.
    Ann Am Thorac Soc; 2014 Jan 27; 11(1):23-9. PubMed ID: 24298907
    [Abstract] [Full Text] [Related]

  • 11. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
    Wallace RJ, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE.
    Chest; 2014 Aug 27; 146(2):276-282. PubMed ID: 24457542
    [Abstract] [Full Text] [Related]

  • 12. Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.
    Moon SM, Yoo IY, Huh HJ, Lee NY, Jhun BW.
    Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31611366
    [Abstract] [Full Text] [Related]

  • 13. Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.
    Daley CL, Winthrop KL.
    J Infect Dis; 2020 Aug 20; 222(Suppl 4):S199-S211. PubMed ID: 32814943
    [Abstract] [Full Text] [Related]

  • 14. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
    Komiya K, Kurashima A, Ihi T, Nagai H, Matsumoto N, Mizunoe S, Ishii H, Takahashi O, Ohta K, Kudoh S, Kadota J.
    Int J Antimicrob Agents; 2014 Aug 20; 44(2):131-5. PubMed ID: 24948577
    [Abstract] [Full Text] [Related]

  • 15. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.
    Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
    Ku JH, Henkle E, Carlson KF, Marino M, Brode SK, Marras TK, Winthrop KL.
    Clin Infect Dis; 2023 Feb 08; 76(3):e1408-e1415. PubMed ID: 35607719
    [Abstract] [Full Text] [Related]

  • 17. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
    Kim HJ, Lee JS, Kwak N, Cho J, Lee CH, Han SK, Yim JJ.
    BMC Pulm Med; 2019 Nov 11; 19(1):212. PubMed ID: 31711459
    [Abstract] [Full Text] [Related]

  • 18. Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease.
    Moon SM, Kim SY, Kim DH, Huh HJ, Lee NY, Jhun BW.
    Antimicrob Agents Chemother; 2022 Apr 19; 66(4):e0202721. PubMed ID: 35266825
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul 19; 6(7):628-34. PubMed ID: 12102303
    [Abstract] [Full Text] [Related]

  • 20. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis.
    Ku JH, Henkle E, Carlson KF, Marino M, Brode SK, Marras TK, Winthrop KL.
    Chest; 2024 May 19; 165(5):1058-1069. PubMed ID: 38086472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.